ask="2.08"
ask_size="100"
average_daily_volume="823060"
bid="2.00"
bid_size="1100"
book_value="1.44"
change="+0.25"
change_from_200_day_moving_average="0.05"
change_from_50_day_moving_average="0.64"
change_from_52_week_high="-4.22"
change_From_52_week_low="1.08"
change_in_percent="+13.66%"
close="2.08"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.92"
ebitda="-8.20M"
eps_estimate_current_year="-0.54"
eps_estimate_next_quarter="-0.24"
eps_estimate_next_year="-0.88"
ex_dividend_date="N/A"
float_shares="4257000"
high="2.09"
high_52_weeks="6.30"
last_trade_date="2/9/2017"
last_trade_price="2.08"
last_trade_size="4635"
last_trade_time="4:00pm"
low="1.76"
low_52_weeks="1.00"
market_capitalization="11.17M"
moving_average_200_day="2.03"
moving_average_50_day="1.44"
name="Cellectar Biosciences
Inc."
notes="N/A"
one_year_target_price="5.07"
open="1.81"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+2.25%"
percent_change_from_50_day_moving_average="+44.41%"
percent_change_from_52_week_high="-66.98%"
percent_change_from_52_week_low="+108.00%"
previous_close="1.83"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.27"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="5368000"
short_ratio="1.11"
stock_exchange="NCM"
symbol="CLRB"
volume="2346731"
weeks_range_52="1.00 - 6.30"
